Trial ID or NCT#

NCT02582697

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.

Official Title

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Eligibility Criteria

Ages Eligible for Study: 11 Years to 45 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Jay Michael S. Balagtas
Sheri Spunt

Contact us to find out if this trial is right for you.

CONTACT

Richard Fu
(650) 497-8815